Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Month: July 2024

Home 2024 July
New Hope in HIV Prevention: Biannual Injections Versus Daily Pill
Post

Revolutionizing HIV Prevention: The Promise of Lenacapavir Injections

The daily use of a pill such as Truvada has been a mainstay of the fight against HIV infections for over a decade. This kind of preventive medication, called pre-exposure prophylaxis, or PrEP, has demonstrated impressive efficacy in clinical trials, with up to 99% success rate in preventing new HIV infections that are contracted through...

Improving Prostate Cancer Outcomes with Advanced PET/CT Imaging Technology
Post

Major Breakthrough in Prostate Cancer Imaging: University of Alberta’s PET/CT Study

In comparison to the traditional MRI method, a new tracing agent for PET/CT imaging provides better accuracy in determining the extent of prostate cancer, as shown by a recent study by researchers at the University of Alberta. This is especially true for intermediate- and high-risk cases. This ground-breaking study, which highlights the important developments in...

osteoporosis
Post

Osteoporosis: The Silent Disease That Strikes Without Warning

Since osteoporosis usually goes undetected until a fracture happens, it is sometimes referred to as an unseen disease. Because there are no visible signs of the internal degradation occurring, the slow weakening of bones remains unnoticed. Nahid J. Rianon, MD, a geriatrician at UT Physicians Center for Healthy Aging – Bellaire Station, explained that although...

From Party Drug to Antidepressant: The Evolution of Slow-Release Ketamine
Post

Ketamine’s New Role: A Slow-Release Pill for Severe Depression

Introduction: Ketamine has shown promise as a treatment for severe depression, despite its initial reputation as a party drug and horse tranquilizer. Although ketamine is often given intravenously in a clinical environment, new developments indicate that a slow-release pill may increase accessibility to this medication and lessen unpleasant side effects. This discovery may be revolutionary...